When assessing the success of a certain pharmacologic treatment for a patient with schizophrenia, there is a distinction to be made between “efficacy” and “effectiveness”. The Canadian Consortium for Early Intervention in Psychosis has created a clinical definition for ‘treatment effectiveness’ based on a sound conceptual framework, currently available evidence and clinical experience. This definition will assist clinicians in evaluating an effective response to treatment which will incorporate efficacy, tolerability and acceptance.
This conceptual framework was created by a national faculty and reviewed by our membership. A slide deck has been developed (see below).
- Project Lead: Dr. Ashok Malla
- Project Sponsor: Otsuka/Lundbeck Alliance